INOINOVIO PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of INOVIO PHARMACEUTICALS, INC. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INO본 종목 | $125M#8 | — | 28.6x#15 | 1914.7x#5 | -70.0%#6 | 20.6%#4 | -132871.3%#5 | -1944.6%#15 | -243.9%#3 | — | -44.4%#12 | — |
| IMUX | $141M#2 | 5.1x#1 | 1.1x#2 | — | — | 3.3%#5 | — | -76.2%#7 | — | — | 25.2%#2 | — |
| CRBP | $141M#3 | — | 1.4x#3 | — | -100.0%#7 | -95.3%#11 | — | -76.8%#8 | -93.1%#2 | — | -37.5%#11 | — |
| APMD | $1.2B#1 | — | — | — | — | — | — | — | — | — | — | — |
| CURX | $135M#4 | — | 28.2x#14 | — | — | -1068.8%#14 | — | -88.2%#11 | — | — | -85.8%#15 | — |
| UNCY | $133M#5 | — | 2.5x#7 | 197.3x#4 | -29.0%#5 | 27.7%#3 | -4372.9%#4 | -49.8%#6 | — | — | 19.6%#6 | — |
| HURA | $133M#6 | — | 7.2x#12 | — | — | -34.8%#8 | — | -167.6%#12 | -0.1%#1 | — | -16.1%#9 | — |
| BMEA | $129M#7 | — | 10.7x#13 | — | — | 55.4%#2 | — | -509.2%#14 | — | — | -8.7%#7 | — |
| AARD | $122M#9 | — | 1.6x#4 | — | — | -179.7%#13 | — | -77.0%#9 | — | — | -49.3%#13 | — |
| EQ | $120M#10 | — | 2.1x#5 | 2.9x#2 | 13.9%#3 | -177.6%#12 | -57.5%#2 | -40.0%#4 | -368.9%#4 | — | 23.5%#3 | — |
| OKUR | $119M#11 | — | 0.7x#1 | — | — | -13.0%#7 | — | -34.6%#3 | — | — | 21.9%#4 | — |
| PMN | $119M#12 | — | 2.4x#6 | — | — | -1529.3%#15 | — | -80.4%#10 | — | — | 19.9%#5 | — |
| GNLX | $114M#13 | — | 7.1x#11 | 14308.8x#6 | 0.0%#4 | -7.6%#6 | -415175.0%#6 | -199.5%#13 | -424.2%#5 | — | -35.5%#10 | — |
| MIST | $114M#14 | — | 6.3x#10 | — | — | -51.9%#10 | — | -0.3%#1 | — | — | -52.7%#14 | — |
| COYA | $111M#15 | — | 2.6x#8 | 14.0x#3 | 123.6%#1 | -42.6%#9 | -283.9%#3 | -49.0%#5 | — | — | -12.2%#8 | — |
| CPIX | $106M#16 | — | 6.1x#9 | 2.4x#1 | 17.6%#2 | 56.2%#1 | -6.3%#1 | -16.3%#2 | — | — | 114.5%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice